Haleos Labs Limited (NSE:HALEOSLABS)
India · Delayed Price · Currency is INR 1,273.10
-5.30 (-0.41%)
At close: Mar 10, 2026
Haleos Labs Market Cap
Haleos Labs has a market cap or net worth of 3.86 billion as of March 10, 2026. Its market cap has increased by 0.44% in one year.
Market Cap
3.86B
Enterprise Value
4.71B
Revenue
3.48B
Ranking
n/a
PE Ratio
19.47
Stock Price
1,273.10
Market Cap Chart
Since August 17, 2017, Haleos Labs's market cap has increased from 407.69M to 3.86B, an increase of 848.02%. That is a compound annual growth rate of 30.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 3.85B | -3.84% |
| Dec 31, 2025 | 4.00B | 12.59% |
| Dec 31, 2024 | 3.56B | 122.05% |
| Dec 29, 2023 | 1.60B | -15.33% |
| Dec 30, 2022 | 1.89B | -14.48% |
| Dec 31, 2021 | 2.21B | 11.54% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Aug 17, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocon | 632.30B |
| Anthem Biosciences | 372.46B |
| OneSource Specialty Pharma | 169.70B |
| Concord Biotech | 126.29B |
| Blue Jet Healthcare | 66.84B |
| Supriya Lifescience | 50.54B |
| Zota Health Care | 40.47B |
| Dishman Carbogen Amcis | 25.75B |